← Back to Search

Neuromodulation

Low-Intensity Focused Ultrasound for Clinical Follow-up

N/A
Waitlist Available
Research Sponsored by Virginia Polytechnic Institute and State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up outcomes assessed throughout participation - an average of 3 weeks.
Awards & highlights
No Placebo-Only Group

Summary

This trialexamines the effects of brain stimulation on muscle contractions to help improve addiction, pain and mental health. Participants have imaging scans and brain stimulation to temporarily affect activity. EMG records the muscle contractions.

Who is the study for?
This trial is for English-speaking individuals willing to use a medication monitoring system. It's not suitable for those with pacemakers, metal implants, history of significant head injury or substance dependence, active CNS-affecting medical conditions, pregnancy, or claustrophobia.
What is being tested?
The study tests how different durations of Low-Intensity Focused Ultrasound (LIFU) affect muscle contractions. Participants will undergo brain imaging and stimulation techniques while their muscle responses are recorded.
What are the potential side effects?
Potential side effects may include discomfort from the ultrasound device, temporary changes in brain activity that could influence mood or cognition, and possible skin irritation at the site of ultrasound application.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~outcomes assessed throughout participation - an average of 3 weeks.
This trial's timeline: 3 weeks for screening, Varies for treatment, and outcomes assessed throughout participation - an average of 3 weeks. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Waveforms

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Duration TrialsExperimental Treatment1 Intervention
Six different durations (three intermittent and three continuous) of LIFU application will be tested across six study sessions. Response recorded using TMS and EMG.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low-Intensity Focused Ultrasound
2020
N/A
~10

Find a Location

Who is running the clinical trial?

Virginia Polytechnic Institute and State UniversityLead Sponsor
155 Previous Clinical Trials
25,600 Total Patients Enrolled

Media Library

Low-Intensity Focused Ultrasound (Neuromodulation) Clinical Trial Eligibility Overview. Trial Name: NCT05147103 — N/A
Long-term Intensive Follow-up for Clinical Purposes Research Study Groups: Duration Trials
Long-term Intensive Follow-up for Clinical Purposes Clinical Trial 2023: Low-Intensity Focused Ultrasound Highlights & Side Effects. Trial Name: NCT05147103 — N/A
Low-Intensity Focused Ultrasound (Neuromodulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05147103 — N/A
~12 spots leftby Jun 2025